Suppr超能文献

血管加压素在循环控制与高血压中的作用

Vasopressin in circulatory control and hypertension.

作者信息

Johnston C I

出版信息

J Hypertens. 1985 Dec;3(6):557-69. doi: 10.1097/00004872-198512000-00001.

Abstract

Recently, there has been an explosion of knowledge on vasopressin, including its neuro-anatomy, biochemistry and physiology. Recent work demonstrates extensive extra-hypothalamic vasopressinergic projections from the SON and PVN. Of particular importance are projections to the cardiovascular medullary centres. Conversely, the SON and PVN receive reciprocal catecholaminergic innervation from autonomic medullary centres. Vasopressin should now be regarded as a peptide hormone with important peripheral effects, as well as a neuropeptide acting as a neurotransmitter or neuromodulator with important CNS actions. The central and peripheral vasopressin systems are not only anatomically differentiated, but, although integrated, may also function independently. There is an important interaction between the central vasopressin system and the autonomic nervous system. Vasopressin has multiple and diverse actions on the cardiovascular system, including direct vasoconstriction, antidiuresis and hence volume control, central actions on cardiovascular neural centres, modulation of the baroreflex and direct cardiac effects. It also acts in concert with the sympathetic nervous system and the renin-angiotensin system as an integrated neurohormonal system in the control of blood pressure. Vasopressin appears to have an important role as a vasoconstrictor agent whenever volume is threatened, such as in dehydration, haemorrhage, adrenal insufficiency and orthostasis. It seems unlikely that vasopressin acts as a direct vasoconstrictor agent in the pathogenesis of any form of experimental or human hypertension. Although plasma vasopressin levels have been reported to be elevated in most forms of hypertension, this correlates best with the severity of hypertension. Furthermore, the levels are not elevated to the pressor range, so that increased vascular reactivity and sensitivity has to invoked. This does not appear to be specific for vasopressin. However, vasopressin may be indirectly involved through volume maintenance or interactions within the CNS. Indeed, its volume retaining properties have probably been underestimated. Whereas in acute situations the vasoconstrictor properties may be of some importance, it is difficult to sustain long-term hypertension without maintenance of an adequate plasma volume. Vasopressin's central actions on the cardiovascular medullary centres, the baroreflex, the autonomic nervous system and catecholamine metabolism may also be involved in some hypertensive processes.(ABSTRACT TRUNCATED AT 400 WORDS)

摘要

最近,关于血管加压素的知识激增,涵盖其神经解剖学、生物化学和生理学。近期研究表明,视上核(SON)和室旁核(PVN)存在广泛的下丘脑外血管加压素能投射。特别重要的是向心血管髓质中枢的投射。相反,视上核和室旁核接受来自自主神经髓质中枢的相互儿茶酚胺能神经支配。血管加压素现在应被视为一种具有重要外周作用的肽类激素,同时也是一种作为神经递质或神经调节剂发挥作用、具有重要中枢神经系统作用的神经肽。中枢和外周血管加压素系统不仅在解剖学上有区别,而且尽管相互整合,但也可能独立发挥作用。中枢血管加压素系统与自主神经系统之间存在重要的相互作用。血管加压素对心血管系统有多种不同作用,包括直接血管收缩、抗利尿从而控制血容量、对心血管神经中枢的中枢作用、压力感受性反射的调节以及对心脏的直接作用。它还与交感神经系统和肾素 - 血管紧张素系统协同作用,作为一个整合的神经激素系统来控制血压。每当血容量受到威胁时,如在脱水、出血、肾上腺功能不全和直立性低血压时,血管加压素似乎作为一种血管收缩剂发挥重要作用。在任何形式的实验性或人类高血压发病机制中,血管加压素似乎不太可能作为直接血管收缩剂起作用。尽管在大多数形式的高血压中,血浆血管加压素水平据报道会升高,但这与高血压的严重程度相关性最佳。此外,这些水平并未升高到升压范围,因此必须考虑血管反应性和敏感性增加的因素。这似乎并非血管加压素所特有。然而,血管加压素可能通过维持血容量或在中枢神经系统内的相互作用而间接参与其中。实际上,其保钠特性可能被低估了。虽然在急性情况下血管收缩特性可能有些重要,但如果不维持足够的血浆容量,就难以维持长期高血压。血管加压素对心血管髓质中枢、压力感受性反射、自主神经系统和儿茶酚胺代谢的中枢作用也可能参与某些高血压过程。(摘要截断于400字)

文献AI研究员

20分钟写一篇综述,助力文献阅读效率提升50倍。

立即体验

用中文搜PubMed

大模型驱动的PubMed中文搜索引擎

马上搜索

文档翻译

学术文献翻译模型,支持多种主流文档格式。

立即体验